Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Int J Mol Sci. 2023 Dec 13;24(24):17426. doi: 10.3390/ijms242417426.
Int J Mol Sci. 2023.
PMID: 38139260
Free PMC article.
Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth.
Blankenship L, Pratap UP, Yang X, Liu Z, Altwegg KA, Santhamma B, Ramasamy K, Konda S, Chen Y, Lai Z, Zheng S, Sareddy GR, Valente PT, Kost ER, Nair HB, Tekmal RR, Vadlamudi RK, Viswanadhapalli S.
Blankenship L, et al.
Cancers (Basel). 2022 Nov 2;14(21):5400. doi: 10.3390/cancers14215400.
Cancers (Basel). 2022.
PMID: 36358818
Free PMC article.
Item in Clipboard
Cite
Cite